Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 97.00 | |
50 mg | In stock | $ 147.00 | |
100 mg | In stock | $ 197.00 | |
500 mg | In stock | $ 489.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes. |
Synonyms | IBC293, IBC-293 |
Molecular Weight | 205.21 |
Formula | C10H11N3O2 |
CAS No. | 306935-41-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (268.02 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IBC 293 306935-41-1 Endocrinology/Hormones GPCR/G Protein GPR GPR109b GPR109A HCAR2 IBC293 PUMA-G Inhibitor GPR109 receptor agonist-1 HCA2 inhibit cardio-metabolic diseases IBC-293 HM74A inhibitor